FALLARINO, Mara
 Distribuzione geografica
Continente #
NA - Nord America 1.530
EU - Europa 535
AS - Asia 167
AF - Africa 20
SA - Sud America 10
Totale 2.262
Nazione #
US - Stati Uniti d'America 1.518
IT - Italia 168
IN - India 79
SE - Svezia 79
UA - Ucraina 70
CN - Cina 63
FI - Finlandia 55
DE - Germania 48
NL - Olanda 35
GB - Regno Unito 26
SG - Singapore 19
TG - Togo 19
CA - Canada 12
BE - Belgio 11
BG - Bulgaria 11
IE - Irlanda 11
RO - Romania 9
AR - Argentina 8
FR - Francia 7
IR - Iran 5
CL - Cile 2
GR - Grecia 2
RU - Federazione Russa 2
KE - Kenya 1
PL - Polonia 1
TH - Thailandia 1
Totale 2.262
Città #
Fairfield 192
Woodbridge 133
Ann Arbor 118
Ashburn 117
Chandler 114
Seattle 74
Dearborn 69
Houston 68
Cambridge 57
Wilmington 56
Princeton 46
Rome 46
Plano 41
Beijing 29
San Paolo di Civitate 25
Jacksonville 23
Lawrence 23
Boston 21
Lomé 19
Des Moines 18
Riverside 16
Helsinki 15
New York 14
San Diego 13
Bremen 12
Millbury 12
Brussels 11
Fremont 11
Sofia 11
Dublin 10
Maserada Sul Piave 10
Singapore 10
Boardman 9
Lendinara 9
Toronto 9
Andover 8
Federal 8
San Mateo 7
Norwalk 6
Pune 6
Nanjing 5
Auburn Hills 4
Falls Church 4
Phoenix 4
Colleferro 3
Guangzhou 3
Ottawa 3
Parma 3
Redwood City 3
Rovigo 3
Xian 3
Buffalo 2
Florence 2
Jinan 2
Kashan 2
Kunming 2
Los Angeles 2
Milan 2
Nanchang 2
Romainville 2
Santa Maria A Monte 2
Torino 2
Trento 2
Wilmslow 2
Zhengzhou 2
Basking Ridge 1
Berlin 1
Chongqing 1
Cork 1
Elmer 1
Frankfurt am Main 1
Fuzhou 1
Gunzenhausen 1
Hangzhou 1
Harbin 1
Hefei 1
Kish 1
Laurel 1
Leawood 1
London 1
Mazzano Romano 1
Nogaredo 1
Padova 1
Palermo 1
Polska 1
Polverara 1
Prescot 1
Provo 1
Redmond 1
San Francisco 1
Sant'elpidio A Mare 1
Scordia 1
Scottsdale 1
Shenyang 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Terni 1
Thessaloniki 1
Trumbull 1
Totale 1.597
Nome #
L’attività ossidante dei monociti circolanti è aumentata in pazienti con diabete di tipo 2 e disfunzione erettile. 157
A case of severe occult ectopic adrenocorticotropin syndrome treated with retrograde venous adrenal ablation using ethanol 112
Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes 108
The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study 98
Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction 85
The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol 81
Antioxidant treatment associated to sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study 78
Antioxidant treatment associated to sildenafil reduces monocyte activation an markers of endothelial damage in patients with diabetes and erectyle dysfunction. 77
Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: A cohort study 71
The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study 70
Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A > T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population 69
Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study 64
Atorvastatin downregulates monocyte CD36 expression, nuclear NFkB levels and TNFalfa production in type 2 diabetes. 63
The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease 62
In pazienti diabetici l’escrezione urinaria di VEGF è correlata all’albuminuria. 60
Assessment of fracture risk by the FRAX algorithm in men and women with and without type 2 diabetes mellitus: a cross- sectional study 58
Atorvastatin Downregulates Monocyte CD36 Expression, Nuclear NF kappa B and TNF alpha Levels in Type 2 Diabetes 58
Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects 56
L’attivita’ ossidante dei monociti circolanti e’ aumentata in pazienti diabetici con disfunzione erettile 55
Waist circumference reduction after insulin detemir therapy in type 2 diabetes patients previously treated with NPH 54
Patient/disease features and glycemic targets in type 2 diabetes: Where do we stand? 54
Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes 53
Prevalenza di bassi livelli di colesterolo HDL e correlazione con il grado di controllo glicometabolico in pazienti con diabete di tipo 2. 52
The Gly482Ser missense mutation of the Peroxisome Proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects. 51
Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2 49
Atorvastatin downregulates monocyte CD36 scavenger receptor expression and nuclear NFkB levels in type 2 diabetic patients. 47
Waist circumference reduction after insulin Detemir therapy in type 2 diabetes patients previously treated with NPH. 45
Patients with type 1 diabetes show a disappearance of the circadian rhythm of heart rate detected by ambulatori blood pressure monitoring. 44
Associazione sesso-specifica tra polimorfismi del recettore 1 del peptide vasoattivo intestinale e diabete di tipo 2 43
Un caso di ipotiroidismo associato a insufficienza renale reversibile e microematuria persistente. 41
Uric acid levels in metabolic syndrome, type 2 diabetes and familial combined hyperlipidemia: a comparison 41
Sindrome metabolica e disfunzione erettile in una popolazione di pazienti obesi non diabetici. 38
The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age 32
Search for genetic variants in the p66Shc longevity gene by PCR-single strand conformational polymorphism in patients with early-onset cardiovascular disease. 32
Does intervention on glycemic control influence HDL cholesterol levels in type 2 diabetes? A pilot study 31
Metabolic Syndrome (MS) and Erectile Dysfunction (ED) among Obese non Diabetic Subjects. 30
Angiotensin blockade and matrix synthesis by glomerular epithelial cells in high glucose: A further experimental insight into the pathophysiology of diabetic nephropathy 27
Effetti del trattamento con atorvastatina sull'espressione del CD36 e sui livelli di NFkB nucleare in monociti circolanti di pazienti con diabete di tipo 2. 27
Il piede diabetico 21
The G972R variant of the insulin receptor substrate-1 (IRS-1) gene is associated with insulin resistance in "uncomplicated" obese subjects evaluated by hyperinsulinemic-euglycemic clamp RID A-1555-2012 21
Search for genetic variants in the retinoid X receptor-gamma gene by polymerase chain reaction-single-strand conformation polymorphism in patients with resistance to thyroid hormone without mutations in thyroid hormone receptor beta gene 21
Totale 2.336
Categoria #
all - tutte 5.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019113 0 0 0 0 0 0 0 0 0 0 64 49
2019/2020521 71 16 9 32 43 110 74 52 46 32 21 15
2020/2021227 16 18 4 24 5 22 39 17 18 23 37 4
2021/2022442 10 27 51 17 52 15 10 37 34 34 84 71
2022/2023458 91 88 30 51 49 58 7 18 47 1 14 4
2023/2024190 16 29 10 17 24 49 1 25 2 17 0 0
Totale 2.336